{"id":8648,"date":"2026-03-19T16:06:04","date_gmt":"2026-03-19T16:06:04","guid":{"rendered":"https:\/\/godshand.link\/ground_post\/genomics-costing-tool-user-manual-2nd-edition\/"},"modified":"2026-03-19T16:06:04","modified_gmt":"2026-03-19T16:06:04","slug":"genomics-costing-tool-user-manual-2nd-edition","status":"publish","type":"ground_post","link":"https:\/\/godshand.link\/en_gb\/ground_post\/genomics-costing-tool-user-manual-2nd-edition\/","title":{"rendered":"Genomics costing tool, user manual, 2nd edition"},"content":{"rendered":"<p><br \/>\n<\/p>\n<section class=\"dynamic-content__section dynamic-content__container\">\n<div class=\"dynamic-content__section-container\">\n<div class=\"dynamic-content__figure-container\">\n<figure class=\"dynamic-content__figure\">\n      <img decoding=\"async\" src=\"https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/11e55780-3f69-48d4-8b91-71c752e4bb7f\/content\" alt=\"Genomics costing tool, user manual, 2nd edition\"><br \/>\n     <\/figure>\n<div class=\"button button-blue-background\"><a target=\"_blank\" href=\"https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/74fda9e3-75a1-41f4-b23c-b2904943c0d4\/content\" onclick=\"sendGaEvent('Download','https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/74fda9e3-75a1-41f4-b23c-b2904943c0d4\/content')\">Download <span>(11.9 MB)<\/span><\/a><\/div><\/div>\n<div class=\"dynamic-content__description-container\">\n<div class=\"row\">\n<div class=\"col-md-8\">\n<div class=\"dynamic-content__description\">\n<h3>Overview <\/h3>\n<div>The second edition of the Genomics Costing Tool builds on the first version, which focused on SARS-CoV-2, by enabling costing a broader range of viral and bacterial pathogens, including influenza and\u00a0<em>Mycobacterium tuberculosis<\/em>. Developed by WHO in collaboration with the Association of Public Health Laboratories, FIND, and the UK Health Security\u00a0Agency, this edition features an expanded list of sequencing platforms and reagents and is designed to remain adaptable as pathogen and technology needs evolve.<\/div>\n<div><\/div>\n<div>The GCT is a Microsoft Excel\u2013based interactive tool supported by a detailed user manual. The manual provides step-by-step guidance for data collection, cost estimation, and interpreting outputs to inform financial planning and resource mobilization for infrastructure, workforce, biosafety, and quality management across genomic surveillance systems.<\/div>\n<div><\/div>\n<div>The tool is intended for policymakers at all levels, health administrators and economists, laboratory leaders, quality managers, donor institutions, and other stakeholders involved in sequencing and bioinformatics for priority pathogens.<\/div>\n<div><\/div>\n<div>The tool is available in English, French, Russian and Spanish. The user manual is currently available in English and will soon be available in French, Russian and Spanish. Training videos will also be released shortly in English, French and Russian to support users in applying the tool.<\/div>\n<div><\/div>\n<div>For any queries regarding the tool or the manual, please, contact\u00a0<a target=\"_blank\" href=\"https:\/\/www.who.int\/publications\/i\/item\/mailto:eulab@who.int\">eulab@who.int<\/a>.<\/div>\n<h5 _ngcontent-dspace-angular-c175=\"\">Relation<\/h5>\n<div _ngcontent-dspace-angular-c175=\"\">Related document (Excel-based interactive costing tool):<br \/><a target=\"_blank\" href=\"https:\/\/iris.who.int\/handle\/10665\/385075\">https:\/\/iris.who.int\/handle\/10665\/385075<\/a><\/div><\/div><\/div>\n<div class=\"col-md-4\">\n<div class=\"dynamic-content__details\">\n<div class=\"detail who-team\">\n<div class=\"label\">WHO Team<\/div>\n<div class=\"value\">\n                 <span><br \/>\nEpidemic and Pandemic Management (EPM)                 <\/span>\n         <\/div><\/div>\n<div class=\"detail\">\n<div class=\"label\">Number of pages<\/div>\n<div class=\"value\">58<\/div><\/div>\n<div class=\"detail\">\n<div class=\"label\">Reference numbers<\/div>\n<div class=\"value\">\n<div><strong class=\"label-sm\">ISBN: <\/strong><span>9789240118843 (electronic version) 9789240118850 (print version)<\/span><\/div><\/div><\/div>\n<div class=\"detail\">\n<div class=\"label\">Copyright<\/div>\n<p>                <a target=\"_blank\" class=\"creativecommons-icons-wrappers\" href=\"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/3\/deed.en\" rel=\"license\" title=\"Click here to see the details of CC BY-NC-SA 3.0 IGO\"><br \/>\n                        <img decoding=\"async\" src=\"https:\/\/www.who.int\/ResourcePackages\/WHO\/assets\/icons\/cc-icons\/cc.svg\"><br \/>\n                        <img decoding=\"async\" src=\"https:\/\/www.who.int\/ResourcePackages\/WHO\/assets\/icons\/cc-icons\/by.svg\"><br \/>\n                        <img decoding=\"async\" src=\"https:\/\/www.who.int\/ResourcePackages\/WHO\/assets\/icons\/cc-icons\/nc.svg\"><br \/>\n                        <img decoding=\"async\" src=\"https:\/\/www.who.int\/ResourcePackages\/WHO\/assets\/icons\/cc-icons\/sa.svg\"><br \/>\n                <\/a>\n        <\/div><\/div><\/div><\/div><\/div><\/div>\n<\/section>\n<p><br \/>\n<br \/><a href=\"https:\/\/www.who.int\/publications\/i\/item\/9789240118843?rand=6398\" target=\"_blank\">Source link <\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Download (11.9 MB) Overview The second edition of the Genomics Costing Tool builds on the first version, which focused on SARS-CoV-2, by enabling costing a broader range of viral and bacterial pathogens, including influenza and\u00a0Mycobacterium tuberculosis. Developed by WHO in collaboration with the Association of Public Health Laboratories, FIND, and the UK Health Security\u00a0Agency, this edition features an expanded list&hellip;<\/p>","protected":false},"author":99035,"featured_media":8649,"parent":0,"menu_order":0,"comment_status":"open","ping_status":"open","template":"","format":"standard","meta":{"give_campaign_id":0,"footnotes":""},"tags":[2111,1584,657,2132,491,922,1853],"ground_category":[315,316],"class_list":["post-8648","ground_post","type-ground_post","status-publish","format-standard","has-post-thumbnail","hentry","tag-2nd","tag-costing","tag-edition","tag-genomics","tag-manual","tag-tool","tag-user","ground_category-2-grounds-tribulation","ground_category-2-1-time-disease"],"fifu_image_url":"https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/11e55780-3f69-48d4-8b91-71c752e4bb7f\/content","_links":{"self":[{"href":"https:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/ground_post\/8648","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/ground_post"}],"about":[{"href":"https:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/types\/ground_post"}],"author":[{"embeddable":true,"href":"https:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/users\/99035"}],"replies":[{"embeddable":true,"href":"https:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/comments?post=8648"}],"version-history":[{"count":0,"href":"https:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/ground_post\/8648\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/media\/8649"}],"wp:attachment":[{"href":"https:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/media?parent=8648"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/tags?post=8648"},{"taxonomy":"ground_category","embeddable":true,"href":"https:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/ground_category?post=8648"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}